Tci Wealth Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$27.56 - $37.75 $2,756 - $3,775	-100 Reduced 20.88%	379 $11,000
Q2 2022 Jul 19, 2022	BUY	$29.79 - $42.29 $1,400 - $1,987	47 Added 10.88%	479 $17,000
Q1 2022 Apr 29, 2022	BUY	$22.96 - $36.45 $1,216 - $1,931	53 Added 13.98%	432 $16,000
Q1 2021 Apr 29, 2021	BUY	$17.21 - $20.65 $6,522 - $7,826	379 New	379 $7,000
Q4 2019 Jan 27, 2020	SELL	$17.07 - $20.64 $3,294 - $3,983	-193 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$19.12 - $22.62 $1,510 - $1,786	-79 Reduced 29.04%	193 $4,000
Q2 2019 Jul 23, 2019	SELL	$18.92 - $22.96 $756 - $918	-40 Reduced 12.82%	272 $6,000
Q1 2019 Apr 11, 2019	SELL	$19.46 - $25.28 $428 - $556	-22 Reduced 6.59%	312 $6,000
Q4 2018 Jan 17, 2019	SELL	$17.72 - $22.51 $212 - $270	-12 Reduced 3.47%	334 $7,000
Q3 2018 Nov 02, 2018	BUY	$15.39 - $19.38 $908 - $1,143	59 Added 20.56%	346 $7,000
Q2 2018 Jul 27, 2018	BUY	$14.63 - $19.6 $4,198 - $5,625	287 New	287 $4,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.